2024
DOI: 10.3389/fendo.2024.1284152
|View full text |Cite
|
Sign up to set email alerts
|

Preoperative glucose-to-lymphocyte ratio predicts survival in cancer

Le Liu,
Bei-bei Zhang,
Yuan-zhou Li
et al.

Abstract: BackgroundSystemic inflammation and glucose metabolism have been closely related to the survival of cancer patients. Therefore, we aimed to evaluate whether preoperative glucose-to-lymphocyte ratio (GLR) can be used to predict the survival of cancer patients.MethodsWe retrospectively examined 2172 cancer patients who underwent surgery from January 1, 2014, to December 31, 2016. There were 240 patients with non-small cell lung cancer (NSCLC), 378 patients with colorectal cancer (CRC), 221 patients with breast c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…GLR is known to play a significant role as a prognostic factor in various cancer types, including NSCLC, CRC, breast cancer, gastric cancer, kidney cancer, liver cancer, esophageal cancer, and melanoma [61]. In our study, unlike research on other cancer types, we expect that GLR, which has a direct relationship with the pancreas that secretes insulin to regulate serum glucose levels, will play a more effective and accurate role in prognostic prediction for pancreatic cancer patients.…”
Section: Discussionmentioning
confidence: 99%
“…GLR is known to play a significant role as a prognostic factor in various cancer types, including NSCLC, CRC, breast cancer, gastric cancer, kidney cancer, liver cancer, esophageal cancer, and melanoma [61]. In our study, unlike research on other cancer types, we expect that GLR, which has a direct relationship with the pancreas that secretes insulin to regulate serum glucose levels, will play a more effective and accurate role in prognostic prediction for pancreatic cancer patients.…”
Section: Discussionmentioning
confidence: 99%